During the past decade, Markusovszky University Teaching Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Markusovszky University Teaching Hospital" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Alkahest, Inc." with 2 trials sponsored, "Aerie Pharmaceuticals" with 1 trials sponsored, "Terumo Europe N.V." with 1 trials sponsored and "Xbrane Biopharma AB" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Markusovszky University Teaching Hospital" #1 collaborator was "Stada Arzneimittel AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Markusovszky University Teaching Hospital" are "Wet Age-related Macular Degeneration" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Coronary Artery Disease" (1 trials), "Macular Degeneration" (1 trials) and "Ocular Hypertension" (1 trials). Many other conditions were trialed in "Markusovszky University Teaching Hospital" in a lesser frequency.

Most popular intervention types in "Markusovszky University Teaching Hospital" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "ALK4290" (2 trials), "Spesolimab" (2 trials), "Avastin" (1 trials), "BI 695502" (1 trials) and "GANFORT®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Markusovszky University Teaching Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Markusovszky University Teaching Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Markusovszky University Teaching Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Markusovszky University Teaching Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".